81 related articles for article (PubMed ID: 15950052)
1. Changes in distribution patterns of integrins in endometrium in copper T380 intrauterine device users.
Oruç S; Vatansever HS; Karaer O; Eskicioğlu F; Narlikuyu B
Acta Histochem; 2005; 107(2):95-103. PubMed ID: 15950052
[TBL] [Abstract][Full Text] [Related]
2. Expression of leukaemia inhibitory factor (LIF) during the window of implantation in copper T380A intrauterine device users.
Güney M; Oral B; Karahan N; Mungan T
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):212-9. PubMed ID: 17763259
[TBL] [Abstract][Full Text] [Related]
3. Abnormal pattern of integrin expression at the implantation window in endometrium from fertile women treated with clomiphene citrate and users of intrauterine device.
Gonzalez RR; Palomino A; Vantman D; Gabler F; Devoto L
Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):132-43. PubMed ID: 11753526
[TBL] [Abstract][Full Text] [Related]
4. Vaginal pH effects caused by OCs and various copper and inert IUDs.
Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
[TBL] [Abstract][Full Text] [Related]
5. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs.
Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675
[TBL] [Abstract][Full Text] [Related]
6. Effect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium.
Coskun E; Cakiroglu Y; Aygun BK; Muezzinoglu B; Caliskan E
Contraception; 2011 Dec; 84(6):637-41. PubMed ID: 22078195
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
8. [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium].
Xin ZM; Xie QZ; Cao LM; Sun YP; Su YC; Guo YH
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):771-5. PubMed ID: 15634506
[TBL] [Abstract][Full Text] [Related]
9. Long-term cytologic studies of copper-IUD users.
Engineer AD; Misra JS; Tandon P
Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
[TBL] [Abstract][Full Text] [Related]
10. Expression of alpha4beta1 and alphavbeta3 integrins in the endometrium of women using the T200 copper intrauterine device.
Savaris R; Zettler CG; Ferrari AN
Fertil Steril; 2000 Dec; 74(6):1102-7. PubMed ID: 11119734
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha(v)beta3 and alpha4beta1 integrins throughout the putative window of implantation in a cohort of healthy fertile women.
Nardo LG; Bartoloni G; Di Mercurio S; Nardo F
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):753-8. PubMed ID: 12174161
[TBL] [Abstract][Full Text] [Related]
12. Expression of integrin subunits alpha2, alpha3, alpha5, alphav, beta1, beta3 and beta4 in different histological types of ameloblastoma compared with dental germ, dental lamina and adult lining epithelium.
Modolo F; Martins MT; Loducca SV; de Araújo VC
Oral Dis; 2004 Sep; 10(5):277-82. PubMed ID: 15315644
[TBL] [Abstract][Full Text] [Related]
13. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
14. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
15. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
Guleria K; Agarwal N; Mishra K; Gulati R; Mehendiratta A
J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
[TBL] [Abstract][Full Text] [Related]
17. The effect of copper intrauterine devices on the expression of mucin 1 and integrin β1 in the luteal phase endometrium.
Calışkan E; Cakıroğlu Y; Coşkun E; Kumbak B; Müezzinoğlu B; Corakçı A
J Turk Ger Gynecol Assoc; 2009; 10(4):194-8. PubMed ID: 24591871
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
19. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
Xuebing P; TinChiu L; Enlan X; Jing L; Xiaowu H
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):198-203. PubMed ID: 21726930
[TBL] [Abstract][Full Text] [Related]
20. [Effects of long-term installation of intrauterine devices on intrauterine microenvironment].
Dong BH; Hou GH; Zhang YZ; Fan J; Zhang P; Li L; Luo X
Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):823-6. PubMed ID: 12895331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
